Benitec Biopharma
BNTC
Benitec Biopharma (BNTC) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Wedbush | Initiated Coverage | Outperform | $16.00 | Jul 28, 2026 |
| Evercore ISI Group | Initiated Coverage | Outperform | $25.00 | May 12, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $32.00 | Mar 9, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $32.00 from $35.00 | Nov 24, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $35.00 from $28.00 | Nov 4, 2025 |
| Citizens | Maintained | Market Outperform | $22.00 from $20.00 | Nov 4, 2025 |
| JMP Securities | Maintained | Market Outperform | $20.00 | Sep 24, 2025 |
| Oppenheimer | Maintained | Outperform | $29.00 from $35.00 | Sep 16, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $28.00 | May 19, 2025 |
| JMP Securities | Maintained | Market Outperform | $20.00 | May 15, 2025 |
| JMP Securities | Maintained | Market Outperform | $20.00 from $18.00 | Apr 10, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $28.00 | Mar 24, 2025 |
| Citizens Capital Markets | Maintained | Market Outperform | $18.00 | Mar 18, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $28.00 | Feb 21, 2025 |
| Baird | Initiated Coverage | Outperform | $30.00 | Dec 13, 2024 |
| Guggenheim | Maintained | Buy | $17.00 | Dec 3, 2024 |
| Oppenheimer | Initiated Coverage | Outperform | $35.00 | Oct 16, 2024 |
| JMP Securities | Maintained | Market Outperform | $18.00 from $16.00 | Oct 14, 2024 |
| JMP Securities | Maintained | Market Outperform | $16.00 | Sep 30, 2024 |
| Guggenheim | Initiated Coverage | Buy | $17.00 | Sep 12, 2024 |
Frequently asked questions
What is the latest analyst rating on BNTC?
On Jul 28, 2026, Wedbush initiated coverage of Benitec Biopharma at Outperform with a price target of $16.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.